Carysil (524091) Aandelenoverzicht
Carysil Limited, samen met haar dochterondernemingen, produceert en verhandelt kwarts keuken- en roestvrijstalen gootstenen, badproducten, tegels, keukenapparatuur en accessoires in India. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 1/6 |
| Toekomstige groei | 3/6 |
| Prestaties in het verleden | 5/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 3/6 |
Beloningen
Risicoanalyse
Geen risico's gedetecteerd voor 524091 uit onze risicocontroles.
524091 Community Fair Values
Create NarrativeSee what 14 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Carysil Limited Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | ₹1,194.95 |
| 52 Week Hoogtepunt | ₹1,280.00 |
| 52 Week Laag | ₹734.00 |
| Bèta | 0.56 |
| 1 maand verandering | 4.27% |
| 3 maanden verandering | 24.58% |
| 1 Jaar Verandering | 49.93% |
| 3 jaar verandering | 72.52% |
| 5 jaar verandering | 100.48% |
| Verandering sinds IPO | 128,851.53% |
Recent nieuws en updates
Narratiefupdate • Jun 18
524091: Subsidiary Simplification And Dividend Plans Will Shape Future Share Performance
Analysts have kept their fair value estimate for Carysil steady at ₹1,270.50, with the small adjustments in discount rate, revenue growth, profit margin and future P/E assumptions leading to only a marginal refinement in the overall price target narrative. What’s in the News for Carysil Board meeting on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on equity shares for the financial year ended March 31, 2026.Narratiefupdate • Jun 02
524091: Subsidiary Simplification And Dividend Policy Will Support Future Upside
Carysil’s analyst price target is unchanged at ₹1,270.5, as analysts balance slightly adjusted assumptions for discount rate, revenue growth, profit margins and future P/E to arrive at the same fair value estimate. What's in the News A board meeting is scheduled for May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on the equity shares for FY 2025-26.Narratiefupdate • May 17
524091: Subsidiary Rationalisation And QIP Extension Will Support Future Upside
Carysil’s analyst price target has changed from ₹1,205.67 to ₹1,270.50 as analysts incorporate slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a modestly higher fair value estimate. What's in the News A board meeting is scheduled on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider and recommend a final dividend, if any, on equity shares for the financial year ended March 31, 2026 (Key Developments).Recent updates
Narratiefupdate • Jun 18
524091: Subsidiary Simplification And Dividend Plans Will Shape Future Share Performance
Analysts have kept their fair value estimate for Carysil steady at ₹1,270.50, with the small adjustments in discount rate, revenue growth, profit margin and future P/E assumptions leading to only a marginal refinement in the overall price target narrative. What’s in the News for Carysil Board meeting on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on equity shares for the financial year ended March 31, 2026.Narratiefupdate • Jun 02
524091: Subsidiary Simplification And Dividend Policy Will Support Future Upside
Carysil’s analyst price target is unchanged at ₹1,270.5, as analysts balance slightly adjusted assumptions for discount rate, revenue growth, profit margins and future P/E to arrive at the same fair value estimate. What's in the News A board meeting is scheduled for May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on the equity shares for FY 2025-26.Narratiefupdate • May 17
524091: Subsidiary Rationalisation And QIP Extension Will Support Future Upside
Carysil’s analyst price target has changed from ₹1,205.67 to ₹1,270.50 as analysts incorporate slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a modestly higher fair value estimate. What's in the News A board meeting is scheduled on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider and recommend a final dividend, if any, on equity shares for the financial year ended March 31, 2026 (Key Developments).Narratiefupdate • Apr 28
524091: Subsidiary Rationalisation And QIP Timeline Extension Will Support Future Upside
Analysts have kept Carysil’s fair value estimate broadly unchanged at about ₹1,205.67, with only small tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, leading to a steady overall price target narrative. What's in the News Board meeting scheduled on Mar 20, 2026 at 15:00 IST to review the appointment of an internal auditor and a cost auditor.Narratiefupdate • Apr 12
524091: Subsidiary Closures And QIP Utilisation Decisions Will Support Future Upside
Analysts have kept their average price target for Carysil broadly steady at around ₹1,205.67, citing largely unchanged assumptions on revenue growth, profit margins and future P/E, with only minor adjustments to the discount rate in their models. What's in the News A board meeting is scheduled on Feb 04, 2026 to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).Narratiefupdate • Mar 28
524091: Upcoming Board Decisions On Subsidiary Closures Will Support Future Upside
Analysts have kept their fair value estimate for Carysil steady at ₹1,205.67 per share, with only minimal tweaks to inputs such as the discount rate, revenue growth outlook, profit margin assumptions and future P/E. This reflects a view that recent data does not materially change the stock’s underlying valuation story.Narratiefupdate • Mar 11
524091: Upcoming Board Results And Stable Assumptions Will Support Future Upside
Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, while making refinements to inputs such as a slightly lower discount rate and minor adjustments to revenue growth, profit margin, and future P/E expectations to reflect updated assumptions in their models. What's in the News Carysil has scheduled a board meeting for February 4, 2026 to review and approve unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).Narratiefupdate • Feb 25
524091: Upcoming Results And Steady Assumptions Will Support Future Upside
Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, making only minor model adjustments, such as a slightly higher discount rate and a modestly higher assumed future P/E multiple. These changes together leave the overall price target unchanged.Narratiefupdate • Feb 11
524091: Upcoming Results And Improved Margin Outlook Will Support Future Upside
Analysts have nudged their fair value estimate on Carysil higher from ₹1,165 to about ₹1,206, citing updated assumptions on discount rate, revenue growth, profit margins and future P/E that better reflect their current expectations for the business. What's in the News Carysil has scheduled a board meeting on February 4, 2026, to consider and approve its unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).Narratiefupdate • Jan 27
524091: Steady Outlook And Upcoming Results Date Will Support Future Upside
Analysts have kept their fair value estimate for Carysil steady at ₹1,165, with only marginal tweaks to inputs like the discount rate and assumed future P/E. This reflects fine tuning of their models rather than a change in their core view.Narratiefupdate • Jan 10
524091: Steady Assumptions And Upcoming Results Will Support Future Upside
Analysts have maintained their price target for Carysil at ₹1,165 per share. This unchanged view mainly reflects consistent assumptions regarding fair value, discount rate, revenue growth, profit margin and future P/E.Narratiefupdate • Dec 15
524091: Capacity Expansion Will Drive Future Earnings Momentum
Analysts have modestly raised their price target on Carysil to ₹1,165 per share (from ₹1,165), reflecting slightly higher discount rate and valuation assumptions while keeping long term growth and margin expectations broadly unchanged. What's in the News Carysil has scheduled a board meeting on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).Narratiefupdate • Dec 01
524091: Capacity Expansion And Dividend Increase Will Drive Upward Momentum
Analysts have raised their price target for Carysil from ₹1,130.33 to ₹1,165.00, citing improved forecasts for revenue growth and profit margins that support a higher fair value estimate. What's in the News A board meeting is scheduled for November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).Narratiefupdate • Nov 16
524091: New Capacity Expansion And Dividend Increase Set To Shape Outlook
Analysts have increased Carysil's fair value estimate from ₹1,039 to ₹1,130.33, citing modest changes in growth forecasts and profit margins, which support a slightly higher valuation target. What's in the News Carysil's board will meet on November 10, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).Narratiefupdate • Aug 18
Global Kitchen Upgrades And Market Expansion Will Transform Industry
Carysil’s consensus price target has been raised to ₹1039, reflecting a notable improvement in future earnings valuation as indicated by the decline in its forward P/E and a marginal uplift in expected revenue growth. What's in the News Board meeting scheduled to consider investment in a subsidiary company.
Nieuw narratief • Feb 18
Partnerships With IKEA And Karran USA Will Drive Global Expansion In Kitchen Solutions
Carysil's global expansion and strategic partnerships in the U.S. are expected to significantly drive revenue growth and increase market presence.Rendement voor aandeelhouders
| 524091 | IN Building | IN Markt | |
|---|---|---|---|
| 7D | 1.4% | 0.9% | 2.2% |
| 1Y | 49.9% | -5.5% | 3.7% |
Rendement versus industrie: 524091 overtrof de Indian Building industrie, die het afgelopen jaar een rendement -5.5 % opleverde.
Rendement versus markt: 524091 overtrof de Indian markt, die het afgelopen jaar een rendement opleverde van 3.7 %.
Prijsvolatiliteit
| 524091 volatility | |
|---|---|
| 524091 Average Weekly Movement | 6.9% |
| Building Industry Average Movement | 6.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 3.7% |
Stabiele aandelenkoers: 524091 heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de Indian markt.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 7% ) van 524091 is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1987 | n/a | Chirag Parekh | www.carysil.com |
Carysil Limited, samen met haar dochterondernemingen, produceert en verhandelt kwartskeuken- en roestvrijstalen gootstenen, badproducten, tegels, keukenapparatuur en accessoires in India. Het bedrijf biedt kranen en keukenafvalvernietigers; keukenoppervlakken; kwarts designtegels; inbouwkeukenapparatuur, waaronder schouwen, kookplaten, wijnkoelers, vaatwassers, inbouwovens, magnetrons, kookplaten, fornuizen, ijs- en koffiezetapparaten en andere producten, en badkamerproducten, waaronder waterclosets, fittingen en kranen. Het bedrijf verkoopt zijn producten onder de merknamen Tekcarysil, Carysil en Sternhagen.
Carysil Limited Samenvatting
| 524091 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | ₹33.51b |
| Inkomsten(TTM) | ₹981.90m |
| Inkomsten(TTM) | ₹9.24b |
34.6x
Koers/Winstverhouding3.7x
P/S-verhoudingIs 524091 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| 524091 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | ₹9.24b |
| Kosten van inkomsten | ₹4.28b |
| Brutowinst | ₹4.96b |
| Overige uitgaven | ₹3.97b |
| Inkomsten | ₹981.90m |
Laatst gerapporteerde inkomsten
Mar 31, 2026
Volgende inkomensdatum
Aug 10, 2026
| Winst per aandeel (EPS) | 34.52 |
| Brutomarge | 53.63% |
| Nettowinstmarge | 10.63% |
| Schuld/Eigen Vermogen Verhouding | 43.9% |
Hoe presteerde 524091 op de lange termijn?
Bekijk historische prestaties en vergelijkingDividenden
0.3%
Huidig dividendrendement9%
UitbetalingsratioBedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/08/05 12:17 |
| Aandelenkoers aan het einde van de dag | 2026/08/05 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2026/03/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Carysil Limited wordt gevolgd door 7 analisten. 3 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Rishab Bothra | Anand Rathi Shares and Stock Brokers Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Vyom Chheda | BP Wealth Management Private Limited |